Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-005196
Filing Date
2025-08-14
Accepted
2025-08-14 17:44:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4229
  Complete submission text file 0001959173-25-005196.txt   5779
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Subject) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36829 | Film No.: 251221391
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address
Schwartz Jonathan David (Reporting) CIK: 0001726398 (see all company filings)

Type: 144